Moore Capital Management, LP Regeneron Pharmaceuticals, Inc. Transaction History

Moore Capital Management, LP

$5.25 Billion
Q2 2024

A detailed history of Moore Capital Management, LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 12,800 shares of REGN stock, worth $13.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

12,800

Previous 17,000 24.71%

Holding current value

$13.3 Million

Previous $16.4 Million 17.78%

% of portfolio

0.26%

Previous 0.27%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $3.71 Million - $4.5 Million	-4,200 Reduced 24.71%	12,800 $13.5 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $5.42 Million - $5.96 Million	6,000 Added 54.55%	17,000 $16.4 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $8.53 Million - $9.7 Million	11,000 New	11,000 $9.66 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $6.8 Million - $8.27 Million	10,000 New	10,000 $8.22 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $10.5 Million - $13.2 Million	18,264 Added 76.98%	41,991 $28.9 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $3.58 Million - $4.82 Million	6,521 Added 37.9%	23,727 $14 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $10.2 Million - $12 Million	17,206 New	17,206 $12 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $24.5 Million - $29 Million	-42,640 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $20.2 Million - $23.8 Million	42,640 New	42,640 $23.8 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $10.2 Million - $12.5 Million	-22,804 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $10.9 Million - $13.9 Million	22,804 New	22,804 $11 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Account

Moore Capital Management, LP Regeneron Pharmaceuticals, Inc. Transaction History